Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies

Patients with hematological malignancies have high risk for morbidity and mortality from influenza. This study was conducted to evaluate the immunogenicity and reactogenicity of an influenza A(H1N1)pdm09 vaccine among such subjects. Fifty subjects were vaccinated twice during the 2009–2010 season. T...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Ide, Yuichiro, Imamura, Yutaka, Ohfuji, Satoko, Fukushima, Wakaba, Ide, Saburo, Tsutsumi, Chiyo, Koga, Masahisa, Maeda, Kazuhiro, Hirota, Yoshio
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2014
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896784/
https://ncbi.nlm.nih.gov/pubmed/25424946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29094
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires